Clinging to a thread of volatility, shares of Panbela Therapeutics, Inc. PBLA plummeted in Monday’s session after the company unveiled the pricing of a $9 million public offering.
Panbela Therapeutics shares nosedived by 65.5% to $1.47 on Monday.
Afflicted with ebbs and flows, the stock market showcased several other players navigating through today’s mid-day session.
Standouts in the Bullish Parade
- Palisade Bio, Inc. PALI spearheaded the gainers with a staggering 133.8% leap to $1.2250, fueled by the company’s withdrawal of a recently filed registration statement. Furthermore, the company unleashed preclinical data of its lead program PALI-2108 at the 2024 Crohn’s & Colitis Congress.
Stragglers in the Bearish Retreat
- SMX (Security Matters) Public Limited Company SMX appeared battered, dropping 24.2% to $0.3259 after a remarkable 83% surge on the prior trading day.
Stocks Take a Tumble Amid Market Uncertainty
Market Overview
- ARVL fell 14.1% to $0.6346.
- J-Long Group Limited JL dipped 12.4% to $8.80 amid post-IPO volatility.
- TAL Education Group TAL fell 10.5% to $10.52. The company recently posted upbeat quarterly sales.
- Cyngn Inc. CYN shares declined 10.4% to $0.2381 after gaining around 24% on Friday.
- MINISO Group Holding Limited MNSO fell 10.3% to $17.76.
- GigaCloud Technology Inc. GCT declined 10.1% to $23.03.
- New Oriental Education & Technology Group Inc EDU dipped 7.7% to $73.77. New Oriental recently reported better-than-expected second-quarter sales results.
- Privia Health Group, Inc. PRVA fell 7.7% to $21.09.
- Bloom Energy Corporation BE fell 7.5% to $11.53 after B of A Securities downgraded the stock from Neutral to Underperform.
- Koninklijke Philips N.V. PHG shares dipped 6% to $21.41 after the company reported fourth-quarter results and agreed on a settlement with the FDA, primarily focusing on Philips Respironics’ business operations in the U.S.
